Edit |   |
---|---|
Antigenic Specificity | VEGFA, Human (Ranibizumab biosimilar) |
Clone | Ranibizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | Fab-G1 kappa |
Format | Fab fragment |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human VEGFA Recombinant Antibody (Ranibizumab). Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. |
Immunogen | n/a |
Other Names | Anti-VEGFA Recombinant Antibody, Research Grade Ranibizumab, Anti-Human VEGFA Recombinant Antibody(Ranibizumab), Fab-12 variant Y0317, RhuFab, Antibody Drug Analogues, Monoclonal Antibody, YR1040, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 347396-82-1 |
Catalog # | YR1040 |
Price | please inquire |
Order / More Info | VEGFA, Human (Ranibizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |